the in vitro activity of amifloxacin ( win 49375 ) , a new fluoroquinolone , was compared with the activities of antimicrobial agents that are commonly used for the treatment of urinary tract infection ( cinoxacin , cephalexin , gentamicin , amoxicillin , trimethoprim , and trimethoprim-sulfamethoxazole ) against 25 strains of staphylococcus saprophyticus and 28 strains of escherichia coli .
C0042029
of urinary tract infection
C0008806
cinoxacin